Oncolytics Biotech $ONCYF reported financial results of Q3. For the quarter ended September 30, 2016, EPS was -$0.03. As of September, the company had $17.7 million in cash, cash equivalents, and short term investments and as of November 2, 2016, it had roughly $16.7 million in cash, cash equivalents and short-term investments.